Amgen (AMGN) Income from Non-Controlling Interests (2016)

Amgen (AMGN) posted quarterly Income from Non-Controlling Interests of $1.0 million for Q2 2016.

Amgen (AMGN) Income from Non-Controlling Interests (2016) Analysis & Trends

Amgen's Income from Non-Controlling Interests history runs 1 years deep, the most recent figure standing at $1.0 million for Q2 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inc. Minority (Qtr)
1	Johnson & Johnson	652.20 Bn	631.44 Bn	17.26 Bn	-
2	AbbVie	469.51 Bn	462.94 Bn	12.70 Bn	3.00 Mn
3	Merck	376.81 Bn	369.67 Bn	12.21 Bn	-2.00 Mn
4	Novartis Ag	303.04 Bn	295.35 Bn	11.24 Bn	-7.00 Mn
5	Astrazeneca	257.61 Bn	252.71 Bn	12.86 Bn	1.00 Mn
6	Amgen	237.37 Bn	223.38 Bn	7.24 Bn	-
7	Gilead Sciences	181.73 Bn	178.55 Bn	6.22 Bn	-
8	Pfizer	159.66 Bn	147.96 Bn	10.94 Bn	10.00 Mn
9	Gsk	106.24 Bn	102.07 Bn	8.24 Bn	741.95 Mn
10	Sanofi	55.07 Bn	47.69 Bn	10.79 Bn	39.52 Mn

Download Data

Date	Value
Jun 30, 2016	1.00 Mn